rockncash| BOCOM International: Maintain the "Buy" rating target price of HK$27.75 for Kingsry Biotechnology

Bank of Communications International released a research report sayingrockncash, maintain the "Buy" rating of Kingsley Biotechnology (01548)rockncash, target price 27rockncash.75 Hong Kong dollars. The bank expects that the approval of Carvykti's new indications will significantly reduce the OOS of the product, gradually release new production capacity, and sales are expected to increase rapidly quarter by quarter starting from the second half of the year. As the investment and financing environment continues to recover, the performance of the CDMO (Prosperous Biology) sector has a chance to exceed expectations. For the life sciences services segment and Bestek, the company guides strong annual revenue growth of 15%-20% and 20%-30%(@CER, comparative effects study).